Skip to Main Content

Paper Details

Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β.
Mult Scler Relat Disord
4
2022
COVID-19, COVID19, COVID19 infection, DMTs, Interferon, MS, dimethyl-fumarate, glatiramer-acetate, interferon, interferon-, interferon-?, multiple sclerosis, patients, people
Author NameAffiliation
Jan HillertSweden Karolinska Institutet
Yves Moreau
Yves Moreau
Helmut ButzkuevenCentral Clinical School, Monash University
Giancarlo ComiCasa di Cura del Policlinico and Universita Vita Salute San Raffaele
  • 1 - 5

Datasets

Release 1.2